Skip to search formSkip to main contentSkip to account menu

12-hydroxyellipticine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Ellipticine is an anticancer agent that forms covalent DNA adducts after enzymatic activation by cytochrome P450 (CYP) enzymes… 
2016
2016
Cytochrome P450 (CYP) 2S1 is “orphan” CYP that is overexpressed in several epithelial tissues and many human tumors. The pure… 
Review
2015
Review
2015
Ellipticine is a DNA-damaging agent acting as a prodrug whose 23 pharmacological efficiencies and genotoxic side effects are… 
2012
2012
The antineoplastic alkaloid ellipticine is a prodrug, whose pharmacological efficiency is dependent on its cytochrome P450 (P450… 
2012
2012
BACKGROUND Ellipticine and doxorubicin are antineoplastic agents, whose action is based mainly on DNA damage such as… 
Highly Cited
2011
Highly Cited
2011
Ellipticine cytotoxicity to cancer cell lines - a comparative study Ellipticine is a potent antineoplastic agent exhibiting… 
2009
2009
OBJECTIVES Ellipticine is a potent antineoplastic agent exhibiting multiple mechanisms of action with promising brain tumor…